Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Connective tissue growth factor (CTGF), also known as CCN2, is a matricellular protein that plays critical roles in cell adhesion, migration, proliferation, angiogenesis, skeletal development, and tissue wound repair. It is especially important in fibrotic diseases and several forms of cancer due to its regulatory effects on extracellular matrix (ECM) production and remodeling. CTGF interacts with multiple receptors, including integrins and LRP6, and modulates signaling pathways such as TGF-beta and Wnt. It is being explored as a therapeutic target for fibroproliferative diseases.
Therapeutics targeting CTGF are under investigation for treating fibrotic diseases due to its pivotal role downstream from TGF-beta signaling cascades that drive pathological ECM accumulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Connective Tissue Growth Factor (CTGF).